INTRODUCTION
Premature infants in the neonatal intensive care unit frequently require small volume red blood cell (RBC) transfusions, or ''topups,'' to replace iatrogenic losses from phlebotomy, to sustain their rapid growth, and to correct the anemia of prematurity. Traditionally, only ''fresh blood'' less than 7 days old had been deemed acceptable for neonatal transfusions. 1 Because the volumes transfused are so small (7 to 15 ml/kg) and the patients require frequent transfusions, this method often resulted in use of many different units of blood for each infant, exposure to multiple donors, and wastage of blood. Many centers have instituted systems to improve blood utilization and reduce donor exposures. In one such system, individual parent units of packed RBCs are divided into multiple smaller packs, so called ''pedipacks.'' All packs derived from an original unit are set aside for use by a single neonate over the course of their hospitalization up until the expiration date of the original parent unit. Despite concerns regarding the safety of this practice, specifically regarding hyperkalemia and depletion of 2,3-diphosphoglycerate (2,3-DPG) that occurs in stored blood, and the concerns regarding the presence of high concentrations of dextrose in extended-storage media, it has been shown that RBCs stored for extended periods of time can be safely transfused to neonates. 2 -12 Since the mid 1980s, our hospital has been using designated pedipacks for packed RBC transfusions to neonatal intensive care unit (NICU) patients. Previously, they were derived from units stored as whole blood in CPDA-1. In August 1993, AS-3 (Nutricel) replaced CPDA-1 as the standard RBC storage medium utilized by the Canadian Red Cross. In keeping with this modification, similar changes were proposed for neonatal transfusions. A pilot project was done to evaluate the safety of using split packs of AS-3 packed RBCs for small volume neonatal transfusions. These split packs were created by using a sterile connecting device to attach three satellite bags onto each unit of blood designated for neonatal transfusions. This system was found to be feasible, sterile, and safe, with no clinical problems encountered in the first 10 babies transfused, and there was a significant decrease in the number of donor exposures to the neonates. We present the results of our first year's experience with the AS-3 stored pedipacks.
MATERIALS AND METHODS
This paper describes our first year's experience using AS-3 stored pedipacks for neonatal transfusions. This was done to demonstrate
OBJECTIVE:
Critically ill neonates frequently require multiple small volume red blood cell ( RBC ) transfusions. RBC units assigned to individual infants, used sequentially in small aliquots until the original expiration date, can substantially reduce donor exposures. In 1993, adenine -saline solution ( AS -3 ) was introduced by the Canadian Red Cross as the red cell storage medium to replace citrate -phosphate -dextrose -adenine anticoagulantpreservative solution ( CPDA -1 ). We surveyed the safety and efficacy of using AS -3 split packs, stored up to 35 days, for premature infants.
STUDY DESIGN:
Units of packed cells were aseptically welded to three satellite bags using a sterile connecting device. When blood was requested for a small volume transfusion, the first satellite bag was used and the others were set aside for the same baby, for use up until their expiration date of 35 days.
RESULTS:
Over a 1 -year period, 56 infants received a total of 263 AS -3 transfusions from 97 donors, with a mean of 4.7 transfusions and 1.7 donor exposures per infant. Following a 7 -ml / kg RBC transfusion, mean rise in hematocrit ( hct ) was 0.04, regardless of the age of the unit, mean change in serum potassium was À 0.16 mmol / l and mean change in total bilirubin was + 1.86 mol / l. The posttransfusion hct was not reduced with the use of the older red cell packs.
CONCLUSION:
Designated AS -3 -preserved split RBC packs effectively limit donor exposures, can safely be used for neonatal small volume transfusions, and give a constant transfusion effect after up to 35 days of storage. 
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the safety and efficacy of using AS-3-preserved RBC split packs as a means to minimize donor exposure for premature infants. Blood was collected from unrelated volunteer donors into CP2D and processed by the Canadian Red Cross Transfusion Service, Montreal, Canada. RBCs were suspended in 100 ml of the additive solution AS-3 (containing 42 mg citric acid, 1100 mg dextrose, 276 mg monobasic sodium phosphate, 410 mg sodium chloride, 588 mg sodium citrate, 30 mg adenine) (Nutricel, Cutter Biologicals, Berkeley CA). The hematocrit (hct) of the AS-3 unit was 0.55 to 0.60, and the volume varied from 320 to 390 ml (see Table 1 ).
When an order for pedipacks was placed by the NICU, ABO and Rh typing and direct antiglobulin test were performed on the baby's heel-stick blood specimen. The ABO, Rh typing and RBC antibody screen was done on the mother within 48 hours before delivery. A fresh AS-3-preserved packed RBC unit that was CMV seronegative, type O, Rh compatible, and antigen negative to any corresponding maternal antibody if present, was assigned to the patient by the Royal Victoria Hospital blood bank. An effort was made to select a unit less than 15 days old to maximize the duration of its use. Full crossmatch (immediate spin, 25% albumin at 378, and with antihuman globulin) was performed using baby's serum. The parent unit had been previously sterile docked to three satellite bags using the Haemonetics ARS 312 sterile connecting device, at the Canadian Red Cross. Parent bags were then well mixed, and separated into four individual split packs on site in the hospital blood bank. The tubing was then heat sealed. Before detaching the units, each one was labeled with complete donor information, including ABO and Rh group, donor number, CMV status, irradiation status, pack number, date of collection, specific antigen testing, blood volume and patient's full identification. The resulting 85-ml aliquots were referred to as packs 1 through 4, and were designated and tagged for one patient only. These packs were available for use until the expiration date of the original unit, set at 35 days from date of collection by Canadian regulations at that time. If serology on the initial request was normal, and there was no untoward reaction to the first transfusion, packs 2 to 4 could be issued consecutively without repeat testing required.
The blood cells were not washed nor irradiated, and no extra manipulation was done before transfusion. Blood was transfused to neonates in small volumes of 7 ml/kg, as per NICU protocol. It was administered over 1 to 3 hours by syringe pump. Clinical status during and after transfusion was monitored by NICU nurses and physicians. Blood drawing for routine biochemistry and complete blood counts was done at the discretion of the neonatologists; in order not to submit the infants to further iatrogenic losses, no additional bloods were drawn solely for the purposes of this study.
We collected data on the sex, birth weight, gestational age, blood type, and age of baby at time of each transfusion. We also looked at the age of the red cells at time of the transfusion, the total number of transfusions received and the total number of donor exposures, as well as pre-and posttransfusion hct, serum potassium, and total, direct, and indirect bilirubin levels. Only laboratory values measured within 12 hours pre-or posttransfusion were included in our calculations.
Statistics
Means, medians and standard deviations were performed using the Microsoft Excel (Microsoft, Redmond, WV) for Windows 95 version 7.0 software package. P values were calculated by the Student-Newman-Keuls test, using Graphpad Instat software (Graphpad Instat, San Diego, CA), version 2.
RESULTS
Fifty-six babies in the Royal Victoria Hospital NICU received small volume transfusions from AS-3-preserved split RBC packs. The babies received a total of 263 transfusions, with a mean of 4.7 transfusions per infant (range 1 to 25). The transfusions were derived from 97 donors, with a mean of 1.7 donor exposures per infant (range 1 to 8). Only eight babies were exposed to three or more donors. The donor to transfusion ratio was 97:263 or 1:2.7 (see Table 2 and Figure 1) .
For the majority of transfusion events (235 of 263), pre-and posttransfusion hct levels are available. The babies attained a mean overall increase in hct of 0.04 (4%) following a 7-ml/kg packed RBC transfusion. Mean and median changes in hct levels were also calculated according to the age of the red cell unit ( <10 days, 10 to 20 days or >20 days old). (See Table 3 ) These numbers show that the response to transfusion was at least as good with the older units as with the fresher ones. The small increase in the mean hct Mangel et al.
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increment with the older packs may be related to greater clinical stability of the older units. Where pre-and postserum potassium (K) and bilirubin were available, there were no significant differences seen. The overall mean change in K (for 108 transfusion events) was À0.16 mmol/l. The mean change in total bilirubin (for 46 transfusions) was +1.86 mol/l (0.1 mg/dl); for direct bilirubin it was +0.60 mol/l (0.03 mg/dl) and for indirect bilirubin it was +1.3 mol/l (0.07 mg/dl). Serum bilirubin levels were not drawn routinely in the neonates, unless they were icteric or receiving total parenteral nutrition. As with the hct, there were no significant increases in K or bilirubin when calculated according to age of the red cell unit or by pack number (data not shown).
No adverse clinical events directly related to blood transfusion were reported by the NICU staff.
DISCUSSION
RBC transfusions are an integral and essential component in the care of premature infants in the NICU. Traditionally, neonatologists have preferred to use only fresh, washed RBCs stored less than 5 to 7 days in CPDA-1 for neonatal transfusion. 1 This practice resulted in an unacceptably high rate of donor exposures, historically up to 8 to 12 per neonate. 13 The reluctance to stray from this policy has been related to theoretical concerns regarding both the safety of long-term storage and the safety of the extended-storage medium itself.
During red cell storage, a rise in extracellular K occurs, there is a pH drop, and a progressive loss of 2,3-DPG causing increased oxyhemoglobin affinity and a drop in p50. 1, 14, 15 In practice, these do not pose clinically significant risks to the neonate. 14 -16 A review article on neonatal transfusions showed that in fact the quantity of K actually infused is negligible in comparison to the neonate's daily requirements, and does not substantially increase the serum potassium. 15 In some studies, measured K levels actually fell after transfusion of stored RBCs. 6 Blood stored in extended-storage media such as AS-1 (Adsol, Baxter Fenwall, Deerfield, IL) or AS-3 (Nutricel) contains higher concentrations of dextrose and adenine than blood stored in CPDA-1 (Table 1) , but this has not been shown to cause untoward transfusion-related effects. 16 From a theoretical perspective, Luban et al. 2 examined the safety of using RBCs preserved in extended-storage media. Using AS-1 as their example, they calculated that the quantities of additives that would be transfused during a neonatal top-up were quite small, therefore unlikely to pose substantial risks, even when used without any additional processing. 17 initially showed that using RBCs stored less than 5 days in AS-1 was safe for neonates, and Strauss et al. 6 later demonstrated that AS-1 RBCs derived from one designated donor per infant and stored up to 42 days were as safe as fresh CPDA-1 RBCs. The assigned units also decreased donor exposures. In view of the small quantity of RBC storage media given and the slow rate of administration, it is felt that routine small volume transfusions stored in preservative nutrient solutions do not pose risks for the majority of premature infants.
14 AS-1 and AS-3 are both nutritive-additive solutions, but there are some differences in the composition and in the concentrations of various nutrients. One hundred milliliters of the additive solution AS-3 contains 1100 mg dextrose, 410 mg sodium chloride, 30 mg adenine, 42 mg citric acid, 276 mg monobasic sodium phosphate, 588 mg sodium citrate, and no mannitol. In contrast, 100 ml of AS-1 contains 2200 mg dextrose, 900 mg sodium chloride, 27 mg adenine, but contains no citric acid, monobasic sodium phosphate or sodium citrate, and does contain 750 mg mannitol. 2 In the studies described above, both the theoretical and the clinical, AS-1 was the storage solution that was tested, and the safety of AS-3 was then inferred after AS-1 was demonstrated to be safe. Only one very recent publication specifically addressed the use of AS-3 for neonatal transfusions, and described two clinical studies conducted in sequence. 12 The first was a randomized trial comparing stored AS-3 RBCs and fresh CPDA-1 RBCs, and the second was an evaluation of subsequent preterm infants given RBCs stored in AS-3. The use of AS-3 RBCs was found to be safe in both studies.
Our study patients received split packs of assigned packed RBC units stored up to 35 days in AS-3 extended-storage solution. Mean donor exposure was only 1.7 per infant, which is a substantial reduction when compared to those of historical controls described in the literature 13 (see Table 4 ). The infants achieved an acceptable rise in their hcts and had no appreciable change in potassium or bilirubin levels pre-and posttransfusion. There were no adverse clinical events directly related to blood transfusion. The majority of previously published data supported the use of AS-1 for neonatal top-ups, 6, 9, 17 and our data supports the most recent results by Strauss et al., 12 providing further evidence in support of AS-3 RBCs, even when stored and used until the date of expiration. We have now been using AS-3 RBCs for neonatal transfusion for over 6 years, and we have continued to obtain good results in our patients.
Limitations to this study include the small number of patients and the incomplete laboratory data; it is possible that some posttransfusion elevations in serum potassium or bilirubin could have gone undetected.
Because only a small proportion of each 85-ml split pack was used per transfusion, blood waste remained quite high. A potential strategy to improve blood utilization and further diminish donor exposures is to attach more satellite bags to the original parent bag. Two institutions have reported on their use of dedicated RBC units spliced to seven satellite bags. 4, 11 Hema-Quebec, the blood supplier that superseded the Canadian Red Cross, now attaches four bags, yielding a total of five 70-ml split packs from each donor unit. Had this modification been in effect in the first year, 10 babies could have been spared one additional donor exposure each. Alternate strategies include using a sterile connecting device for repeated entry into a RBC unit to prepare small volume aliquots, 3,5 -7 use of a designated ''superdonor'' to provide all the transfusion needs of an individual neonate, 6 collection and banking of autologous placental blood, and administration of recombinant erythropoietin. 18 Some investigators have used a model to predict which infants were or were not likely to require ongoing and frequent transfusions, and assigned them to individual or shared RBC units accordingly. 3, 7 Based on the results obtained in this study, the authors conclude that a protocol using assigned units of AS-3 packed RBCs spliced to multiple satellite bags used until their date of expiration effectively limits donor exposures, and is simple, efficient, and safe when used for small volume neonatal transfusions. 
